Research articlePublished 3 May 2019
Simultaneous Estimation of Atorvastatin and Ezetimibe in Pharmaceutical Formulations by RP-HPLC Method
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Atorvastatin and Ezetimibe are used to treat hyperlipidemia. A simple, precise cost effective and stability indicating RP-HPLC method has been developed and validated for the simultaneous determination of Atorvastatin and Ezetimibe in pharmaceutical formulations. Separation of both Atorvastatin and Ezetimibe was achieved with in 5 minutes with required resolution, accuracy and precision thus enabling the utility of the method for routine analysis. Chromatographic separation was achieved on a Waters Symmetry C18 3.5μm, 150 mm x 3.0 mm using a mobile phase consisting of 0.05M phosphate buffer pH3.0 and Acetonitrile in the ratio of 45:55 at a flow rate of 0.8ml per minute. The detection was made at 236nm. The retention time of Atorvastatin and Ezetimibe were2.5 and 2.0 minutes respectively. The method was found linear over the range of 5-15 μg per ml for Ezetimibe and 40-120 μg per ml for Atorvastatin. The proposed method was validated as per the ICH and USP guidelines.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalDer Pharmacia Lettre
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Jayapal Reddy Sama”
- BylineArticles whose byline prints “Rama Rao Kalakuntla”
- BylineArticles whose byline prints “V. Surya Narayanac Rao”
- BylineArticles whose byline prints “P. Reddanna”